• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.79% Nasdaq Up0.53%

    Sorrento Therapeutics, Inc. (SRNE)

    -NasdaqCM
    17.21 Down 0.41(2.33%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 3,825   460   584  
    Cost of Revenue2,043  4   -  
    Gross Profit 1,782   456   584  
    Operating Expenses
    Research Development23,983  9,017  3,830  
    Selling General and Administrative9,987  6,317  1,606  
    Non Recurring209  5,986   -  
    Others2,345  804   -  
    Total Operating Expenses36,524  22,124   -  
    Operating Income or Loss (34,742) (21,668) (4,852)
    Income from Continuing Operations
    Total Other Income/Expenses Net12  10  7  
    Earnings Before Interest And Taxes(34,730)(21,658)(4,845)
    Interest Expense1,629  253   -  
    Income Before Tax(36,359)(21,911)(4,845)
    Income Tax Expense(1,702) -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(34,657)(21,911)(4,845)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (34,657) (21,911) (4,845)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (34,657) (21,911) (4,845)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.